|
1
|
Shields CL and Shields JA: Retinoblastoma
management: Advances in enucleation, intravenous chemoreduction,
and intra-arterial chemotherapy. Curr Opin Ophthalmol. 21:203–212.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jabbour P, Chalouhi N, Tjoumakaris S,
Gonzalez LF, Dumont AS, Chitale R, Rosenwasser R, Bianciotto CG and
Shields C: Pearls and pitfalls of intraarterial chemotherapy for
retinoblastoma. J Neurosurg Pediatr. 10:175–181. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Abramson DH, Marr BP, Brodie S, Dunkel IJ
and Gobin PY: Intraarterial chemotherapy for kissing macula tumors
in retinoblastoma. Retin Cases Brief Rep. 6:209–211. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Meel R, Radhakrishnan V and Bakhshi S:
Current therapy and recent advances in the management of
retinoblastoma. Indian J Med Paediatr Oncol. 33:80–88. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Erhard F, Haas J, Lieber D, Malterer G,
Jaskiewicz L, Zavolan M, Dölken L and Zimmer R: Widespread context
dependency of microRNA-mediated regulation. Genome Res. 24:906–919.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang B, Pan X, Cobb GP and Anderson TA:
microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar
|
|
9
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang Y and Mei Q: miRNA signature
identification of retinoblastoma and the correlations between
differentially expressed miRNAs during retinoblastoma progression.
Mol Vis. 21:1307–1317. 2015.
|
|
11
|
Beta M, Venkatesan N, Vasudevan M,
Vetrivel U, Khetan V and Krishnakumar S: Identification and
insilico analysis of retinoblastoma serum microRNA profile and gene
targets towards prediction of novel serum biomarkers. Bioinform
Biol Insights. 7:21–34. 2013.PubMed/NCBI
|
|
12
|
Kang S, Zhao Y, Hu K, Xu C, Wang L, Liu J,
Yao A, Zhang H and Cao F: miR-124 exhibits antiproliferative and
antiaggressive effects on prostate cancer cells through PACE4
pathway. Prostate. 74:1095–1106. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xia H, Cheung WK, Ng SS, Jiang X, Jiang S,
Sze J, Leung GK, Lu G, Chan DT, Bian XW, et al: Loss of
brain-enriched miR-124 microRNA enhances stem-like traits and
invasiveness of glioma cells. J Biol Chem. 287:9962–9971. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang X, Liu Y, Liu X, Yang J, Teng G,
Zhang L and Zhou C: miR-124 inhibits cell proliferation, migration
and invasion by directly targeting SOX9 in lung adenocarcinoma.
Oncol Rep. 35:3115–3121. 2016.PubMed/NCBI
|
|
15
|
Feng T, Shao F, Wu Q, Zhang X, Xu D, Qian
K, Xie Y, Wang S, Xu N, Wang Y, et al: miR-124 downregulation leads
to breast cancer progression via LncRNA-MALAT1 regulation and
CDK4/E2F1 signal activation. Oncotarget. 7:16205–16216.
2016.PubMed/NCBI
|
|
16
|
Jiang L, Lin T, Xu C, Hu S, Pan Y and Jin
R: miR-124 interacts with the Notch1 signalling pathway and has
therapeutic potential against gastric cancer. J Cell Mol Med.
20:313–322. 2016. View Article : Google Scholar
|
|
17
|
Xi ZW, Xin SY, Zhou LQ, Yuan HX, Wang Q
and Chen KX: Downregulation of rho-associated protein kinase 1 by
miR-124 in colorectal cancer. World J Gastroenterol. 21:5454–5464.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cheng Y, Li Y, Nian Y, Liu D, Dai F and
Zhang J: STAT3 is involved in miR-124-mediated suppressive effects
on esophageal cancer cells. BMC Cancer. 15:3062015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li W, Huang H, Su J, Ji X, Zhang X, Zhang
Z and Wang H: miR-124 acts as a tumor suppressor in glioblastoma
via the inhibition of signal transducer and activator of
transcription 3. Mol Neurobiol. Mar 18–2016.Epub ahead of
print.
|
|
20
|
Lu Y, Yue X, Cui Y, Zhang J and Wang K:
MicroRNA-124 suppresses growth of human hepatocellular carcinoma by
targeting STAT3. Biochem Biophys Res Commun. 441:873–879. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li X, Yu Z, Li Y, Liu S, Gao C, Hou X, Yao
R and Cui L: The tumor suppressor miR-124 inhibits cell
proliferation by targeting STAT3 and functions as a prognostic
marker for postoperative NSCLC patients. Int J Oncol. 46:798–808.
2015.
|
|
22
|
Wu X, Zeng Y, Wu S, Zhong J, Wang Y and Xu
J: MiR-204, down-regulated in retinoblastoma, regulates
proliferation and invasion of human retinoblastoma cells by
targeting CyclinD2 and MMP-9. FEBS Lett. 589:645–650. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sun Z, Zhang A, Jiang T, Du Z, Che C and
Wang F: MiR-145 suppressed human retinoblastoma cell proliferation
and invasion by targeting ADAM19. Int J Clin Exp Pathol.
8:14521–14527. 2015.
|
|
24
|
Wang J, Wang X, Li Z, Liu H and Teng Y:
MicroRNA-183 suppresses retinoblastoma cell growth, invasion and
migration by targeting LRP6. FEBS J. 281:1355–1365. 2014.
View Article : Google Scholar
|
|
25
|
Zhang T, Wang J, Zhai X, Li H, Li C and
Chang J: MiR-124 retards bladder cancer growth by directly
targeting CDK4. Acta Biochim Biophys Sin. 46:1072–1079. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang H, Wang Q, Zhao Q and Di W: MiR-124
inhibits the migration and invasion of ovarian cancer cells by
targeting SphK1. J Ovarian Res. 6:842013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lang Q and Ling C: MiR-124 suppresses cell
proliferation in hepatocellular carcinoma by targeting PIK3CA.
Biochem Biophys Res Commun. 426:247–252. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Turkson J: STAT proteins as novel targets
for cancer drug discovery. Expert Opin Ther Targets. 8:409–422.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Masuda M, Suzui M, Yasumatu R, Nakashima
T, Kuratomi Y, Azuma K, Tomita K, Komiyama S and Weinstein IB:
Constitutive activation of signal transducers and activators of
transcription 3 correlates with cyclin D1 overexpression and may
provide a novel prognostic marker in head and neck squamous cell
carcinoma. Cancer Res. 62:3351–3355. 2002.PubMed/NCBI
|
|
30
|
Wei D, Le X, Zheng L, Wang L, Frey JA, Gao
AC, Peng Z, Huang S, Xiong HQ, Abbruzzese JL, et al: Stat3
activation regulates the expression of vascular endothelial growth
factor and human pancreatic cancer angiogenesis and metastasis.
Oncogene. 22:319–329. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xie TX, Wei D, Liu M, Gao AC, Ali-Osman F,
Sawaya R and Huang S: Stat3 activation regulates the expression of
matrix metalloproteinase-2 and tumor invasion and metastasis.
Oncogene. 23:3550–3560. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Furtek SL, Backos DS, Matheson CJ and
Reigan P: Strategies and approaches of targeting STAT3 for cancer
treatment. ACS Chem Biol. 11:308–318. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Suh YA, Jo SY, Lee HY and Lee C:
Inhibition of IL-6/STAT3 axis and targeting Axl and Tyro3 receptor
tyrosine kinases by apigenin circumvent taxol resistance in ovarian
cancer cells. Int J Oncol. 46:1405–1411. 2015.
|
|
34
|
Chai EZ, Shanmugam MK, Arfuso F,
Dharmarajan A, Wang C, Kumar AP, Samy RP, Lim LH, Wang L, Goh BC,
et al: Targeting transcription factor STAT3 for cancer prevention
and therapy. Pharmacol Ther. 162:86–97. 2016. View Article : Google Scholar
|
|
35
|
Jo DH and Kim JH, Cho CS, Cho YL, Jun HO,
Yu YS, min JK and Kim JH: STAT3 inhibition suppresses proliferation
of retinoblastoma through down-regulation of positive feedback loop
of STAT3/miR-17-92 clusters. Oncotarget. 5:11513–11525. 2014.
View Article : Google Scholar : PubMed/NCBI
|
